- Alcami has entered a definitive agreement to acquire Tjoapack, a contract packaging organization with facilities in Tennessee and The Netherlands.
- The deal creates a transatlantic contract manufacturing platform offering U.S.-Europe supply chain redundancy, with closing expected in Q2 2026.
Alcami Corporation has agreed to acquire Tjoapack, a contract packaging organization (CPO) with over 35 years of experience serving the pharmaceutical and biotechnology industries. The transaction, announced April 21, 2026, marks Alcami’s first European expansion and is expected to close in the second quarter of this year, subject to customary closing conditions.
Tjoapack operates facilities in Clinton, Tennessee, and Etten-Leur, The Netherlands, running 23 packaging lines and employing more than 400 personnel. The company provides primary and secondary packaging and labeling services across oral solid dose, sterile injectables, and kitting formats, supporting more than 40 commercial markets globally.
The acquisition will enable Alcami to offer U.S. supply chain redundancy for packaging and labeling alongside Qualified Person (QP) release and related services in Europe. Tjoapack clients will gain access to Alcami’s pharmaceutical testing labs, sterile and oral solid dose drug product manufacturing, and GMP pharma storage — reducing supplier hand-offs for customers operating across multiple markets.
“This acquisition marks our first European expansion which is an essential element of our investment strategy to expand our presence in the global market,”
Patrick Walsh, Chairman and CEO of Alcami.
“This transaction represents an important next chapter for Tjoapack. Partnering with Alcami allows us to accelerate our growth ambitions while staying true to what has made Tjoapack successful – quality, reliability, and a strong focus on our customers,” said Dexter Tjoa, CEO of Tjoapack.
PharmaSource recently interviewed the Tjoapack team about the questions to ask contract packaging partners:
Both companies share a common investor: Ampersand Capital Partners holds a stake in Alcami alongside GHO Capital and The Vistria Group, and is the majority owner of Tjoapack. Financial terms of the transaction were not disclosed.
